(NASDAQ: QNTM) Quantum Biopharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 141.94%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.93%.
Quantum Biopharma's earnings in 2025 is -$15,238,008.On average, 1 Wall Street analyst forecast QNTM's earnings for 2025 to be -$3,822,630, with the lowest QNTM earnings forecast at -$3,822,630, and the highest QNTM earnings forecast at -$3,822,630.
In 2026, QNTM is forecast to generate -$3,117,748 in earnings, with the lowest earnings forecast at -$3,117,748 and the highest earnings forecast at -$3,117,748.